# A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540

> **NCT01557335** · PHASE1 · COMPLETED · sponsor: **POZEN** · enrollment: 30 (actual)

## Conditions studied

- Platelet Aggregation

## Interventions

- **DRUG:** Plavix® and PA32540
- **DRUG:** EC aspirin (Bayer®) ,EC omeprazole (Prilosec®) , Clopidogrel (Plavix®)

## Key facts

- **NCT ID:** NCT01557335
- **Lead sponsor:** POZEN
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01557335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01557335, "A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01557335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*